Form 4 for GILD Gilead Sciences
Accepted 2022-11-02 00:00:00 ET · period of report 2022-11-01 · accession 0001127602-22-024778 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-02 | 2022-11-01 | GILD | Wilfong Diane E. | SVP, CAO, Ctrl | M - OptEx | $72.70 | +16.3K | 44.6K | +57% | +$1.18M |
| D | 2022-11-02 | 2022-11-01 | GILD | Wilfong Diane E. | SVP, CAO, Ctrl | S - Sale+OE | $79.25 | -16.3K | 28.3K | -36% | -$1.29M |
| D | 2022-11-02 | 2022-11-01 | GILD | Wilfong Diane E. | SVP, CAO, Ctrl | M - OptEx | $0.00 | -16.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-01 | M | A | 16,255 | $72.70 | 44,588 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-01 | S | D | 16,255 | $79.25 | 28,333 | D | — | — | |
| 3 | Derivative | Non-qualified Stock Option (Right to Buy) | 2022-11-01 | M | D | 16,255 | $0.00 | 0 | D | $72.70 · — to 2027-08-10 | 16,255 Common Stock | (F1) The shares subject to the option have a three year vesting schedule. 33.33% vest on the first anniversary of the date of the grant. The balance will vest 8.33% quarterly thereafter until fully vested. |